World's Best Scientists 2026 revealed!
Diethelm Wallwiener

Diethelm Wallwiener

D-Index & Metrics

Medicine

D-Index
77
Citations
22854
World Ranking
18391
National Ranking
968

Diethelm Wallwiener publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Diethelm Wallwiener sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 885 publications — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Diethelm Wallwiener D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Diethelm Wallwiener sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 77 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Diethelm Wallwiener is affiliated with the University of Tübingen in Germany and has an extensive research portfolio primarily in the fields of medicine and biochemistry, genetics, and molecular biology. Their work encompasses a significant focus on oncology, with contributions covering various aspects of cancer research including pulmonary and respiratory medicine, genetics, and surgery.

The scientist's publication record includes numerous articles in peer-reviewed journals, with frequent contributions to leading venues such as Geburtshilfe und Frauenheilkunde, Senologie - Zeitschrift für Mammadiagnostik und -therapie, Archives of Gynecology and Obstetrics, European Journal of Cancer, and Cancers.

Key research topics covered by Diethelm Wallwiener include:

  • Advanced Breast Cancer Therapies
  • HER2/EGFR in Cancer Research
  • Breast Cancer Treatment Studies
  • Cancer Genomics and Diagnostics
  • Cancer Treatment and Pharmacology
  • Monoclonal and Polyclonal Antibodies Research
  • Cancer Cells and Metastasis

Notable recent papers authored or co-authored by Diethelm Wallwiener are:

  • Prognostic effect of low-level HER2 expression in patients with clinically negative HER2 status, 2021, European Journal of Cancer
  • Mutations in BRCA1/2 and Other Panel Genes in Patients With Metastatic Breast Cancer -Association With Patient and Disease Characteristics and Effect on Prognosis, 2021, Journal of Clinical Oncology
  • Living-Donor Uterus Transplantation: Pre-, Intra-, and Postoperative Parameters Relevant to Surgical Success, Pregnancy, and Obstetrics with Live Births, 2020, Journal of Clinical Medicine
  • Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial, 2024, Clinical Chemistry
  • Initial experience with CDK4/6 inhibitor-based therapies compared to antihormone monotherapies in routine clinical use in patients with hormone receptor positive, HER2 negative breast cancer - Data from the PRAEGNANT research network for the first 2 years of drug availability in Germany, 2020, The Breast

Throughout their career, Diethelm Wallwiener has collaborated extensively with a group of frequent co-authors, including Sara Y. Brucker, Tanja Fehm, Andreas Schneeweiß, Peter A. Fasching, and Andreas D. Hartkopf. These collaborations have contributed to a substantial body of work primarily centered on breast cancer treatment and diagnostics.

Wallwiener's research spans both clinical studies and molecular investigations, with a particular emphasis on therapeutic approaches and diagnostic advancements in oncology. Their contributions cover the clinical outcomes of breast cancer therapies, mutations affecting prognosis, and surgical parameters relevant to transplantation and birth outcomes.

Best Publications

  • Reduction in New Metastases in Breast Cancer with Adjuvant Clodronate Treatment

    Ingo J. Diel;Erich-Franz Solomayer;Serban D. Costa;Christina Gollan

  • Clinical aspects of Mayer–Rokitansky–Kuester–Hauser syndrome: recommendations for clinical diagnosis and staging

    Peter Oppelt;Stefan P. Renner;Anja Kellermann;Sara Brucker

  • Detection and Typing of Human Papillomavirus by E6 Nested Multiplex PCR

    K. Sotlar;D. Diemer;A. Dethleffs;Y. Hack

  • HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

    Tanja Fehm;Volkmar Müller;Bahriye Aktas;Wolfgang Janni

  • Expression of stem cell and epithelial-mesenchymal transition markers in primary breast cancer patients with circulating tumor cells

    Sabine Kasimir-Bauer;Oliver Hoffmann;Diethelm Wallwiener;Rainer Kimmig

  • Proteomics of Human Breast Ductal Carcinoma in Situ

    Julia D. Wulfkuhle;Dennis C. Sgroi;Henry Krutzsch;Kelley McLean;Kelley McLean

  • Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.

    Christina S. Schuetz;Michael Bonin;Susan E. Clare;Kay Nieselt

  • Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells

    Tanja Fehm;Oliver Hoffmann;Bahriye Aktas;Sven Becker

  • The VCUAM (Vagina Cervix Uterus Adnex-associated Malformation) classification: a new classification for genital malformations.

    Peter Oppelt;Stefan P. Renner;Sara Brucker;Pamela L. Strissel

  • A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation

    Tanja Fehm;Stephan Braun;Volkmar Muller;Wolfgang Janni

  • Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial.

    J. Huober;J. Huober;P.A. Fasching;P.A. Fasching;M. Barsoum;L. Petruzelka

  • Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma

    Claudia Lengerke;Tanja Fehm;Ralf Kurth;Hans Neubauer

  • Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status

    Tanja Fehm;Sven Becker;Silke Duerr-Stoerzer;Karl Sotlar

  • High prevalence of viral genomes and inflammation in peripartum cardiomyopathy.

    Burkhard D. Bültmann;Karin Klingel;Michael Näbauer;Diethelm Wallwiener

  • Is human chorionic gonadotropin directly involved in the regulation of human implantation

    P. Licht;H. Fluhr;J. Neuwinger;D. Wallwiener

  • Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer

    Ines Gruber;Miriam Rueckert;Karl Oliver Kagan;Annette Staebler

  • Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer.

    Axel Hoos;Axel Hoos;Hedwig H. Hepp;Sepp Kaul;Thorsten Ahlert

  • PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study

    Brigitte Smyczek-Gargya;Nikos Fersis;Helmut Dittmann;Ulrich Vogel

  • A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regard to quality assurance.

    Thorsten Kuehn;Andreas Bembenek;Thomas Decker;Dieter Ludwig Munz

  • Chemokine bioactivity of RANTES in endometriotic and normal endometrial stromal cells and peritoneal fluid.

    D. Hornung;F. Bentzien;D. Wallwiener;L. Kiesel

Frequent Co-Authors

Tanja Fehm
Tanja Fehm Heinrich Heine University Düsseldorf
Andreas Schneeweiss
Andreas Schneeweiss German Cancer Research Center
Peter A. Fasching
Peter A. Fasching University of Erlangen-Nuremberg
Matthias W. Beckmann
Matthias W. Beckmann University of Erlangen-Nuremberg
Volkmar Müller
Volkmar Müller Universität Hamburg
Nadia Harbeck
Nadia Harbeck Ludwig-Maximilians-Universität München
Michael Untch
Michael Untch Helios Klinikum Berlin-Buch
Christoph Thomssen
Christoph Thomssen University of Göttingen
Jens Huober
Jens Huober Kantonsspital St. Gallen
Arnulf Stenzl
Arnulf Stenzl University of Tübingen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in medical careers beyond traditional doctor routes? Many students considering studying Medicine in the USA also explore other respected healthcare pathways—and online options make these fields more accessible than ever.

For those drawn to pharmaceuticals, consider pursuing pharmacy school online, which allows you to continue working or meeting other obligations while earning a degree. Similarly, if managing health data interests you, accredited him programs offer a flexible route to careers in data management, compliance, and informatics.

Medical billing and coding is another respected field, and understanding medical coding certification cost can help you budget for one of the fastest-growing allied health careers. Nursing remains an ever-popular healthcare path, with numerous cheapest fnp programs online letting you prepare for advanced practice roles affordably.

Exploring these alternative degrees can expand your career options, allow greater work-life balance, and help you find a healthcare role that best matches your strengths and interests.

Best Scientists Citing Diethelm Wallwiener

Trending Scientists

Recently Published Articles